Radotinib Intermediate
have 0 Relevant products
Radotinib Is A New Selective Inhibitor Of Tyrosine Kinase Bcr-Abl1. Its Ic50 Value Is 34Nm For Wild-Type Bcr-Abl1. It Is A Drug For Different Types Of Cancer. The Most Notable One Is Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Cml), Which I
